Principles and Approaches for Optimizing Therapy With Unique Topical Vehicles

December 2014 | Volume 13 | Issue 12 | Features | 1431 | Copyright © December 2014


Jamie Rosen BA, Angelo Landriscina BA, and Adam J. Friedman MD

confers liposomes amphipathic properties, enabling encapsulation of hydrophilic and hydrophobic drugs.23 Liposomal carriers increase drug stability, enhance their therapeutic effects, and promote uptake of the drug into target tissues.23,24 Given the instability of liposomes within aqueous solutions, Ning et al. prepared clotrimazole-containing proliposomes for vaginal application. These prolipisomes were found to be capable of sustained release for 24 hours and efficacious against Candida albicans as seen by a decrease in colony forming units by day 7.25 Multilamellar vesicles are even capable of depositing a high concentration of finasteride in the follicular region for the treatment of androgenic alopecia.26 Pornpattananangkul et al observed that liposomal lauric acid was able to fuse with bacterial membranes, effectively eradicating Proprionibacterium acnes infection in a mouse model, with minimal toxicity to unaffected skin.27 Further in vitro and in vivo studies evaluated the effect of fluconazoleloaded liposomes; authors found a higher accumulation of drug following liposomal gel application compared to control, with a significantly higher retention within the stratum corneum.23 The ability of liposomes to penetrate the epidermis may be explained by their lipid composition, facilitating greater penetration compared to other vehicle forms. It has also been proposed that the lipid matrix is able to intercalate with skin lipids, enabling loosening of the encapsulated drug and thus accelerating its release.22 However, despite their improved permeation, confocal microscopy found that liposomes were confined to the stratum corneum and unable to penetrate the granular layers of the epidermis.28
Microspheres
Microspheres are another technological approach to deliver low-dose sustained release treatment to control a variety of skin disease. Microsphere technology eliminates the rapid delivery of highly concentrated drug to the application site, allowing for the sustained release of active drug. Microsphere technology effectively traps the active ingredient at the skin surface, enhancing drug delivery at the application site while limiting systemic distribtion.29 While retinoids and benzoyl peroxide are extremely effective in controlling acne vulgaris, therapy-associated irritation is a serious complaint that limits patient compliance.30 Eichenfield et al demonstrated a statistically significant reduction in the number of noninflammatory acne lesions after treatment with tretinoin microsphere 0.04% gel compared to empty vehicle.31 In another study, there was no significant difference in tolerability (ie, erythema, dryness, itching, stinging) of the same microsphere drug when compared to tretinoin 0.025% cream applied to healthy skin, despite the increased concentration of tretinoin in the drug of interest.32 Furthermore, topical microsphere-based fluorouracil, has proven effective in the treatment of actinic keratoses (AK) with a significant reduction in AK lesion counts and lesion clearance compared to vehicle control.29 There are currently a variety of topical microsphere formulations on the market, each with increased efficacy and reduced irritability compared to traditional vehicles.
Nanoparticles
Nanoparticles are another innovative carrier being investigated and used in skin disease to harness potent drugs, allow for targeted drug delivery, and minimize systemic side effects.33 Given their high surface-to-volume ratio, small size and stability, nanoparticles are able to surpass barriers, penetrate the stratum corneum and accumulate at target sites.34,35 There are multiple pre-clinical programs in dermatology evaluating the utility of these carriers. Friedman et al encapsulated and enhanced the efficacy of benzoyl peroxide, finding improved antimicrobial efficacy against P. acnes at lower concentrations compared to native benozyl peroxide with less toxicity to eukaryotic cells.35 In an in vivo murine MRSA intramuscular abscess study, which compared the efficacy of topical and intralesional nitric oxide releasing nanoparticles (NO-np) with systemic vancomycin, all treatment arms accelerated the rate at which the abscesses improved clinically. However, topical and intralesional NO-np significantly decreased bacterial survival as determined by tissue cultures as well as by histology, which demonstrated less inflammatory infiltrate and muscle necrosis as compared to other groups.36 A spherical nucleic acid carrying gold nanoparticle (SNA-NC), when mixed with a commercial moisturizing cream (aquaphor), allowed for topical delivery of gene-targeting therapeutics into deep layers of the skin without barrier disruption.37 SNA-NC was capable of freely penetrating into keratinocytes, mouse skin and human epidermis in concentrations sufficient to induce morphological change via EGFR gene knockdown, an important signaling molecule in epidermal cell proliferation and frequently overexpressed in malignancy.37 Lastly, nanotechnology is allowing topical delivery of botulinum toxin, with reported similar effects to its injected formulation.38 A purified 150kD botulinum toxin combined with a peptidyl macromolecule transport system, a combination permitting transepidermal flux of toxin into the dermis, was applied to subjects with moderate-to-severe lateral canthal lines, revealing significant improvement in wrinkling compared to placebo at both rest and smile.39 Together, these investigations highlight nanoparticle systems as a promising new approach for targeted drug delivery, one which can hopefully combat difficult to treat dermatologic conditions and improve drug efficacy and patient compliance.

Conclusion

While topical drug delivery is a pillar of dermatologic therapy, the choice of vehicle is a crucial decision that can significantly alter efficacy, outcomes and patient compliance. An effective topical management program is dependent on the properties of the vehicle—physical chemistry, ease of applicability and penetration of drug. Topical treatment of skin disease allows for local delivery and rapid absorption of a high concentration of active drug; however, the skin’s intrinsic function, to counteract the penetration of foreign substances by creating a physical barrier from the external environment, makes drug